Vaxcyte Inc (PCVX) — the earnings record

Computed on 2026-09-18 from the vendor's per-print history with the Print Record's method — no desk-written read yet. An investment research diary, not advice.

The record at a glance

4/10EPS beats
0/10revenue beats
3 · 4 · 3up · flat · down (+3d, ±3%)
2026-11-03next print

Reactions across the covered prints span -10.1% to +8.9% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries est EPS $-2.12 · est revenue ~$0.01B into the next print.

Print by print

PrintDateEPSRevenue
Aug 26 2026-08-05 ✓ beat ✗ miss
May 26 2026-05-06 ✗ miss ✗ miss
Feb 26 2026-02-24 ✗ miss ✗ miss
Nov 25 2025-11-04 ✗ miss ✗ miss
Aug 25 2025-08-06 ✗ miss ✗ miss
May 25 2025-05-07 ✗ miss ✗ miss
Feb 25 2025-02-25 ✓ beat ✗ miss
Nov 24 2024-11-05 ✓ beat ✗ miss
Aug 24 2024-08-06 ✗ miss ✗ miss
May 24 2024-05-08 ✓ beat ✗ miss

Report-day close to the close three sessions later on adjusted closes, ±3% bands — the same method as every hand-written card; the Print Record method explains the bands. No reaction chart, metric line or behavior read exists for PCVX yet.

FAQ · from the current data · as of 2026-09-18

Quick answers

How often does Vaxcyte Inc beat earnings estimates?

Across the last 10 covered prints (as of the 2026-09-18 card), Vaxcyte Inc beat EPS estimates 4 of 10 times and revenue estimates 0 of 10 times, with 0 double beats.

How does PCVX stock react to earnings?

Measured close-of-print-day to the close three sessions later: 3 of the last 10 prints resolved up (beyond +3%), 4 flat, 3 down — reactions spanning -10.1% to +8.9%. Beat-or-miss and reaction are scored separately because they frequently disagree.

What was PCVX's biggest earnings reaction?

-10.1% over the three sessions after the Aug 25 print (2025-08-06).

When does Vaxcyte Inc report earnings next?

2026-11-03 (2026-11-03 · est EPS $-2.12 · est revenue ~$0.01B). This record is computed from the vendor's per-print history with the Print Record's method; a desk-written card for PCVX does not exist yet. An investment research diary, not advice.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.